A Dynamic Change
in Lung Function Assessment
Our mission is to provide zero-contact, non-aerosol generating technology to actively assess lung function, and to create reliable diagnostic pathways in order to establish an enhanced standard of care.
Our mission is to provide next generation assessment for patients and faster, smarter processes via our innovative SLP technology focused on tidal breathing, for the care provider.
Non-invasiveRespiratory Assessment
Monitoring real-time regional respiratory function via movement of the chest wall
PneumaCareThora-3Di® Systems
Offer a fully integrated architecture in terms of hardware and software
About PneumaCare
PneumaCare Ltd is a Cambridge based company, pioneers of the technology – Structured Light Plethysmography (SLP). Our revolutionary, respiratory imaging system provides assessment solutions, that are non-contact, non-invasive and non-aerosol generating. Breaking new ground, PneumaCare Ltd are at the forefront in changing the face of assessment in the respiratory field.
"I use the Thora-3Di® regularly in my clinical work and it is a valuable assessment tool. It enables me to visualise and quantify presentations, as well as helping me to communicate the findings with patients. If I ever have a problem, the technical support from PneumaCare is very responsive"
Dr Nicki Barker, Advanced Physiotherapist, Principal Clinical Researcher, Sheffield Children's NHS Foundation Trust
"SLP is set to revolutionise our understanding of respiratory physiology as it adds a new dimension to understanding of the mechanics and patterns of breathing in our respiratory patients. We are beginning to see the enormous potential this brilliant innovative technique has in our understanding of how the lungs are effected by disease or recover from surgery. Pneumacare have been, bold, supportive and visionary in supporting our research and the development of this amazing technology. The patient benefits from what we are learning will be far reaching and ground-breaking for respiratory medicine.”
Dr Brendan Cooper, Consultant Clinical Scientist, Hon.Senior Research Fellow, Queen Elizabeth, Birmingham
"The measurement of lung function changes in children with respiratory diseases is essential if we are to accurately assess the benefit of treatments. Non-invasive, simple methods have been sought for decades and the technique developed by Pneumacare is exciting and novel. The system offers a completely different approach and can be applied to all age groups. If accurate, reproducible and sensitive results can be obtained, I can foresee the technique having wide application in all centres specialising in the management of paediatric respiratory illnesses."
Prof. Warren Lenney, Dept Child Health, University Hospital of North Staffordshire, Stoke on Trent
"Structured light plethysmography (SLP) opens the door on "tidal PFTs", and it does so while eliminating observer and instrumentation biases. I am very enthusiastic about the cooperative project that is beginning between Pneumacare and my research group."
Prof. Thomas Similowski, Head of Respiratory Medicine and Intensive Care at the Pitié-Salpêtrière Hospital, Paris
"Our centre is currently trialling SLP in the work-up of pre-operative cardiothoracic patients. We feel it is intuitive to use and, therefore, does not require trained technicians, resulting in increased patient throughput and lower costs to the department. Importantly, SLP offers clinicians continuous measurement of mechanical chest wall displacement, a surrogate marker for fatigability and neuromuscular strength."
Shyam Kolvekar MBBS, MS, MCh, FRCPS, FRCS, FRCSCTh
Consultant Cardiothoracic Surgeon Lead, Chest Wall Surgery Bart’s Heart Centre St Bartholomew
"SLP is a viable alternative to spirometry, especially in the current pandemic, Spirometry remains the gold-standard PFT, however, the field would certainly benefit from studies evaluating the sensitivity, specificity and clinical validity of SLP in impairment detection, against gold-standard PFT."
Natalie Simon M.Sc. MBBS
Academic Foundation Doctor, Cambridge University NHS Foundation Trust